U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 199

1.
Value/Rank Plot

Slc3a1 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Slc3a1, solute carrier family 3, member 1
Organism:
Mus musculus
Reporter:
GPL6246, 10447264 (ID_REF), GDS5419, NM_009205, BC013441, D88533, chr17:85028376-85064241 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
2.
Value/Rank Plot

MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6246, 10608652 (ID_REF), GDS5419, control (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
3.
Value/Rank Plot

Mir195a - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Mir195a, microRNA 195a
Organism:
Mus musculus
Reporter:
GPL6246, 10377802 (ID_REF), GDS5419, NR_029581, chr11:70235042-70235135 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
4.
Value/Rank Plot

Vmn1r47 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Vmn1r47, vomeronasal 1 receptor 47
Organism:
Mus musculus
Reporter:
GPL6246, 10539965 (ID_REF), GDS5419, NM_053219, chr6:90021840-90022820 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
5.
Value/Rank Plot

Klra6 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Klra6, killer cell lectin-like receptor, subfamily A, member 6
Organism:
Mus musculus
Reporter:
GPL6246, 10548497 (ID_REF), GDS5419, NM_008464, U10092, chr6:130013033-130026960 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
6.
Value/Rank Plot

Rltpr - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Rltpr, RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing
Organism:
Mus musculus
Reporter:
GPL6246, 10574825 (ID_REF), GDS5419, NM_001033320, BC115830, HF678090, AK051288, chr8:105686274-105698165 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
7.
Value/Rank Plot

Prss37 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Prss37, protease, serine 37
Organism:
Mus musculus
Reporter:
GPL6246, 10544263 (ID_REF), GDS5419, NM_026317, BC125467, BC125493, chr6:40514824-40519508 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
8.
Value/Rank Plot

MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6246, 10442025 (ID_REF), GDS5419, chr17:16014880-16015137 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
9.
Value/Rank Plot

MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6246, 10343346 (ID_REF), GDS5419, control (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
10.
Value/Rank Plot

Nup210 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Nup210, nucleoporin 210
Organism:
Mus musculus
Reporter:
GPL6246, 10546294 (ID_REF), GDS5419, NM_018815, XM_006506400, AF113751, BC052468, chr6:91013068-91116826 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
11.
Value/Rank Plot

MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6246, 10608686 (ID_REF), GDS5419, control (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
12.
Value/Rank Plot

Mir301 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Mir301, microRNA 301
Organism:
Mus musculus
Reporter:
GPL6246, 10379996 (ID_REF), GDS5419, NR_029652, chr11:87113004-87113089 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
13.
Value/Rank Plot

MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6246, 10343303 (ID_REF), GDS5419, control (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
14.
Value/Rank Plot

MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
No annotation available
Organism:
Mus musculus
Reporter:
GPL6246, 10421875 (ID_REF), GDS5419, chr14:86311289-86311387 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
15.
Value/Rank Plot

Olfr873 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Olfr873, olfactory receptor 873
Organism:
Mus musculus
Reporter:
GPL6246, 10583446 (ID_REF), GDS5419, NM_146561, BC139140, chr9:20300211-20301170 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
16.
Value/Rank Plot

Tdpoz2 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Tdpoz2, TD and POZ domain containing 2
Organism:
Mus musculus
Reporter:
GPL6246, 10499961 (ID_REF), GDS5419, NM_001007222, BC141104, chr3:93651571-93652663 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
17.
Value/Rank Plot

Doc2g - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Doc2g, double C2, gamma
Organism:
Mus musculus
Reporter:
GPL6246, 10460291 (ID_REF), GDS5419, NM_021791, AB046665, AK052869, BC061104, AK084565, chr19:4003321-4007005 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
18.
Value/Rank Plot

Kcna7 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Kcna7, potassium voltage-gated channel, shaker-related subfamily, member 7
Organism:
Mus musculus
Reporter:
GPL6246, 10552932 (ID_REF), GDS5419, NM_010596, AF032099, AY779767, chr7:45405960-45411382 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
19.
Value/Rank Plot

Olfr393 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Olfr393, olfactory receptor 393 (multiple annotations exist)
Organism:
Mus musculus
Reporter:
GPL6246, 10388286 (ID_REF), GDS5419, NM_001159775, NM_147005, NM_001005780, NM_146347, NM_146923, NM_147007, NM_147008, NM_207224, BC138172, BC138173, chr11:73798817-73799755 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
20.
Value/Rank Plot

Zfp42 - MEK inhibitor PD-0325901 and rapamycin combined treatment effect on malignant peripheral nerve sheath tumor model

Annotation:
Zfp42, zinc finger protein 42
Organism:
Mus musculus
Reporter:
GPL6246, 10578401 (ID_REF), GDS5419, NM_009556, BC053399, BC098467, M28382, chr8:43295037-43306980 (SPOT ID)
DataSet type:
Expression profiling by array, transformed count, 8 samples
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Profile data

Download profile data help

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center